187 related articles for article (PubMed ID: 11083845)
1. Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils.
Weingart CL; Mobberley-Schuman PS; Hewlett EL; Gray MC; Weiss AA
Infect Immun; 2000 Dec; 68(12):7152-5. PubMed ID: 11083845
[TBL] [Abstract][Full Text] [Related]
2. Bordetella pertussis virulence factors affect phagocytosis by human neutrophils.
Weingart CL; Weiss AA
Infect Immun; 2000 Mar; 68(3):1735-9. PubMed ID: 10679000
[TBL] [Abstract][Full Text] [Related]
3. Phagocytosis of Bordetella pertussis incubated with convalescent serum.
Mobberley-Schuman PS; Connelly B; Weiss AA
J Infect Dis; 2003 May; 187(10):1646-53. PubMed ID: 12721945
[TBL] [Abstract][Full Text] [Related]
4. Fluorescent labels influence phagocytosis of Bordetella pertussis by human neutrophils.
Weingart CL; Broitman-Maduro G; Dean G; Newman S; Peppler M; Weiss AA
Infect Immun; 1999 Aug; 67(8):4264-7. PubMed ID: 10417202
[TBL] [Abstract][Full Text] [Related]
5. Effects of adenylate cyclase toxin from Bordetella pertussis on human neutrophil interactions with Coccidioides immitis and Staphylococcus aureus.
Galgiani JN; Hewlett EL; Friedman RL
Infect Immun; 1988 Apr; 56(4):751-5. PubMed ID: 2894360
[TBL] [Abstract][Full Text] [Related]
6. Influence of CR3 (CD11b/CD18) expression on phagocytosis of Bordetella pertussis by human neutrophils.
Mobberley-Schuman PS; Weiss AA
Infect Immun; 2005 Nov; 73(11):7317-23. PubMed ID: 16239529
[TBL] [Abstract][Full Text] [Related]
7. The C-terminal domain is essential for protective activity of the Bordetella pertussis adenylate cyclase-hemolysin.
Betsou F; Sebo P; Guiso N
Infect Immun; 1995 Sep; 63(9):3309-15. PubMed ID: 7642260
[TBL] [Abstract][Full Text] [Related]
8. Phagocytosed Bordetella pertussis fails to survive in human neutrophils.
Lenz DH; Weingart CL; Weiss AA
Infect Immun; 2000 Feb; 68(2):956-9. PubMed ID: 10639471
[TBL] [Abstract][Full Text] [Related]
9. The Bordetella adenylate cyclase repeat-in-toxin (RTX) domain is immunodominant and elicits neutralizing antibodies.
Wang X; Gray MC; Hewlett EL; Maynard JA
J Biol Chem; 2015 Feb; 290(6):3576-91. PubMed ID: 25505186
[TBL] [Abstract][Full Text] [Related]
10. Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxin.
Lee SJ; Gray MC; Guo L; Sebo P; Hewlett EL
Infect Immun; 1999 May; 67(5):2090-5. PubMed ID: 10225859
[TBL] [Abstract][Full Text] [Related]
11. Blockade of the Adenylate Cyclase Toxin Synergizes with Opsonizing Antibodies to Protect Mice against Bordetella pertussis.
DiVenere AM; Amengor D; Silva RP; Goldsmith JA; McLellan JS; Maynard JA
mBio; 2022 Aug; 13(4):e0152722. PubMed ID: 35920558
[No Abstract] [Full Text] [Related]
12. Antibodies to Bordetella pertussis adenylate cyclase toxin in neonatal and maternal sera.
Arciniega JL; Hewlett EL; Edwards KM; Burns DL
FEMS Immunol Med Microbiol; 1993 Apr; 6(4):325-30. PubMed ID: 8499896
[TBL] [Abstract][Full Text] [Related]
13. Both adenylate cyclase and hemolytic activities are required by Bordetella pertussis to initiate infection.
Khelef N; Sakamoto H; Guiso N
Microb Pathog; 1992 Mar; 12(3):227-35. PubMed ID: 1614333
[TBL] [Abstract][Full Text] [Related]
14. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
Macdonald-Fyall J; Xing D; Corbel M; Baillie S; Parton R; Coote J
Vaccine; 2004 Oct; 22(31-32):4270-81. PubMed ID: 15474718
[TBL] [Abstract][Full Text] [Related]
15. Pertussis toxin and lipopolysaccharide influence phagocytosis of Bordetella pertussis by human monocytes.
Schaeffer LM; Weiss AA
Infect Immun; 2001 Dec; 69(12):7635-41. PubMed ID: 11705943
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of monocyte oxidative responses by Bordetella pertussis adenylate cyclase toxin.
Pearson RD; Symes P; Conboy M; Weiss AA; Hewlett EL
J Immunol; 1987 Oct; 139(8):2749-54. PubMed ID: 2888823
[TBL] [Abstract][Full Text] [Related]
17. Bordetella pertussis adenylate cyclase: effects of affinity-purified adenylate cyclase on human polymorphonuclear leukocyte functions.
Friedman RL; Fiederlein RL; Glasser L; Galgiani JN
Infect Immun; 1987 Jan; 55(1):135-40. PubMed ID: 2878884
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant and protective properties of native and recombinant Bordetella pertussis adenylate cyclase toxin preparations in mice.
Hormozi K; Parton R; Coote J
FEMS Immunol Med Microbiol; 1999 Apr; 23(4):273-82. PubMed ID: 10225286
[TBL] [Abstract][Full Text] [Related]
19. Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis.
Weiss AA; Hewlett EL; Myers GA; Falkow S
J Infect Dis; 1984 Aug; 150(2):219-22. PubMed ID: 6088647
[TBL] [Abstract][Full Text] [Related]
20. Bordetella pertussis adenylate cyclase. Purification, characterization, and radioimmunoassay.
Ladant D; Brezin C; Alonso JM; Crenon I; Guiso N
J Biol Chem; 1986 Dec; 261(34):16264-9. PubMed ID: 2877986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
